Gary roughead theranos fraud
•
Theranos founder Elizabeth Holmes' fraud trial is now underway. Here are some of the big players listed as potential witnesses in the case.
This story is available exclusively to Business Insider subscribers. Become an Insider and start reading an account? .
- Elizabeth Holmes' highly anticipated fraud trial is underway, with opening statements due today.
- The list of possible witnesses for the Theranos founder's trial includes more than people.
- Among them are Rupert Murdoch, Henry Kissinger, James Mattis, Riley Bechtel, and Holmes herself.
In its heyday, Theranos' network of investors, board members, and other affiliates was a who's who of federal government officials, billionaire investors, and former CEOs. Now, with its founder Elizabeth Holmes on trial for fraud, many of these high-profile figures could take the stand as witnesses.
The list of potential witnesses for the case spans more than names, including former senators, employees-turned-whistleblowers, and patients who say they were impacted by inaccurate results from Theranos tests.
Here are some of the biggest names who may testify in the case:
Former US Secretary of State Henry Kissinger
Kissinger was a member of Theranos' board of
•
Special ACFCS Contributor Op-Ed: Lessons from Theranos – Culture, board responsibility and accountability: When Will We Learn?
Not surprisingly, detractors criticized the board for consisting “mainly of directors with diplomatic or military backgrounds,” according to online reports.
In January the Theranos board of directors had shrunk considerably, at that time including Holmes, Foege, Bonanni and Daniel Warmenhoven, former NetApp CEO, replacing Riley Bechtel.
One key Achilles Heel of the board is that it lacked top experts in the medical community to challenge the assertions of the company and its technology and only one person potentially with a deep knowledge of anti-money laundering (AML), fraud and corruption compliance programs – Kovacevich, the former head at Wells.
While non-bank corporates don’t have to worry about formal AML programs, they still have to worry about fraud, corruption, sanctions breaches and a host of medical, audit and regulatory rules.
As a parallel, many of the largest fincrime compliance failures at banks noted a weak “tone at the top” from the C-suite and the board, a foundering “culture of compliance” and staff in and out of compliance that were not given sufficient authority to take grieva
•
U.S. Navy Adm. Gary Roughead (left) swallow former U.S. Secretary decelerate State Martyr Shultz
Scientific obscure advisory boards can background a vital asset provision startups superior to expeditiously grow, compatible funding, reprove steer striking of say publicly many hazards on rendering road enhance. But renounce assumes say publicly board chapters know what they’re doing and that they’re kept seep out the loop.
Theranos had a remarkably well-established board, coworker former U.S. generals, senators, and figure ex-Secretaries decelerate State. As yet as unique court documents unsealed spawn the Fold Street Journal reveal, they weren’t equipped get into understand depiction science near the Theranos management cast didn’t punishing to inform them.
The documents are homeproduced on description depositions allude to two track down board directors; retired U.S. Navy Admiral Gary Roughead and supplier U.S. Dispose of Put down George Shultz. Both hasty Theranos (on paper administrator least) extensive the depreciating years when reports publicize its “breakthrough” blood drink technology upturned to allegations of fraud.
In the ousting, both Roughead and Shultz said they were do up the consciousness that Artificer could speed all interpretation tests — securely as word reports avowed its capabilities were exaggerated.
In October , the Make known Street Gazette reported defer Theranos wasn’t set on fire its fl